Day: December 19, 2022

U.S. FDA Approves Lung Cancer Drug, Adagrasib

Adagrasib
The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated locally [...]